Krabbe disease DNA testing for Irish Setter health

The Irish setter puppies are known for their striking deep red coat and energetic nature, making them delightful pets for those able to meet their active lifestyle needs. However, like many breeds, they are susceptible to certain hereditary conditions, one of the most serious being globoid cell leukodystrophy, also known as Krabbe disease.

Originally bred as gun dogs registered in the UK Kennel Club's gundog group, Irish setters are now more commonly cherished as family companions. Their high energy and love of outdoor activity require substantial exercise, while their beautiful coats demand regular grooming to maintain shine and minimise shedding indoors.

This breed generally enjoys a relatively long lifespan of 10-15 years, but unfortunately, some dogs may be affected by inherited diseases such as globoid cell leukodystrophy (GLD). GLD is a rare, fatal neurological disorder caused by a deficiency of the lysosomal enzyme galactocerebrosidase (GALC). This enzyme deficiency results in the build-up of toxic substances like psychosine that damage the protective myelin sheath of nerve cells, leading to progressive nervous system decline.

What is globoid cell leukodystrophy or Krabbe disease in Irish Setters?

GLD, or Krabbe disease, typically appears during early puppyhood—between one to three months of age. Affected dogs initially seem healthy but soon develop symptoms including muscle weakness, tremors, uncoordinated movements (ataxia), behavioural changes, seizures, loss of motor control, and even blindness or deafness. These neurological signs worsen progressively, usually resulting in death or humane euthanasia within the first year because the condition has no cure.

How is globoid cell leukodystrophy inherited in Irish Setters?

Globoid cell leukodystrophy is inherited in Irish setters via an autosomal recessive pattern. This means a puppy must inherit two copies of the defective GALC gene mutation—one from each parent—to develop the disease. Carriers have one defective gene but do not show symptoms themselves. Knowing the genetic status of prospective parent dogs allows breeders to make informed mating choices to prevent producing affected puppies.

If both parents are carriers, there is a 25% chance of affected puppies, 50% chance of carriers, and 25% chance of clear puppies.
If one parent is affected and the other a carrier, there's a 50% chance of affected puppies and 50% chance of carriers.
Breeding two clear dogs will produce litters free from the disease.

Why DNA testing matters for Irish Setter breeders

Because globoid cell leukodystrophy is fatal and untreatable, prevention through careful breeding is essential. DNA testing for the GALC mutation is widely available in the UK and is a critical tool for breeders committed to maintaining the health and wellbeing of Irish setters. By testing breeding stock, carriers and affected dogs can be identified, and breeding plans adjusted accordingly to avoid mating carriers to carriers or affected dogs.

Testing process: A simple DNA sample is collected by a vet—usually via cheek swab or blood sample—and sent to an accredited laboratory. Results typically come back in a few weeks, informing breeders of a dog’s genetic status as clear, carrier, or affected.

Responsible breeding practices to reduce disease risk

Reputable Irish setter breeders routinely test for globoid cell leukodystrophy as part of their health screening protocols. Responsible breeders will never knowingly breed two carriers or affected dogs together, aiming instead to pair carriers only with clear dogs to gradually eliminate the defective gene from the population while preserving genetic diversity.

Early genetic awareness combined with veterinary guidance supports the gradual reduction of globoid cell leukodystrophy in the breed without compromising the wider gene pool or the breed's desired characteristics.

What to do if you’re an Irish Setter owner or considering one

If you own an Irish setter or are considering adding one to your family, it is wise to ask your breeder or shelter about any DNA health testing performed, including screening for globoid cell leukodystrophy. If you already have a dog and are planning to breed, consult your vet about testing to understand your dog’s status and how it may affect breeding choices.

Being informed helps protect the breed’s future and ensures your companion’s health and comfort.

Summary

Globoid cell leukodystrophy (Krabbe disease) is a fatal inherited neurological condition in Irish setters caused by GALC enzyme deficiency.
Symptoms typically appear early in puppyhood and include neurological decline leading to death usually within the first year.
The disease is inherited autosomal recessively; both parents must carry the defective gene for puppies to be affected.
DNA testing is available and essential for responsible breeding to prevent affected litters.
Currently, there is no cure, so preventative breeding strategies are vital for the breed’s health.

For more information or to find reputable breeders who test for this condition, always consult veterinary specialists and recognised breeder clubs associated with Irish setters.